Rituximab Exerts a Dual Effect in Pemphigus Vulgaris
Rüdiger Eming(Philipps University of Marburg), Michael Hertl(Universitätsklinikum Gießen und Marburg), Dirk Debus(Nuremberg Hospital), Angela Nagel(Philipps University of Marburg), Eva Podstawa(Philipps University of Marburg), Sonja Wolff‐Franke(Universitätsklinikum Gießen und Marburg)
Cited by 180
Related Papers
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|586
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|373
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|370
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332
Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)
|Journal of the European Academy of Dermatology and Venereology|2022|247